This month we’re pleased to introduce accelopment Schweiz AG, our EXIMIOUS partner in the lead for the project’s communication, dissemination and exploitation . Based in Zürich, Switzerland, accelopment has been a sparring partner in the acquisition, management and communication and dissemination support of EU funded projects for research and innovation since 2008.

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome Watch the EXIMIOUS-EPHOR Joint Symposium at IOHA 2021 16 November 2021 You can now rewatch the symposium titled ‘Exposure assessment in the exposome context – need for precise – broad-scope – external exposure assessment’, which was held at the IOHA 2021 international conference (11-15 September

Headquartered in Brussels, Belgium, the Louvain Centre for Toxicology and Applied Pharmacology is a leading hub for research in the adverse effects of pollutants. The Centre brings together expertise in clinical, analytical, experimental and epidemiological sciences.

More than 60 participants joined on the afternoon of 15 June 2021 to learn more about key aspects of exposome-immunome interactions at different stages of life, looking into ways of measuring the internal exposome and the effects of occupational settings.

Register now and join us online at 16:00 – 18:00 (CET) for the first EXIMIOUS Symposium “Exposome-immunome interactions: A broad introduction”.

Headquartered in Leuven, Belgium, Imec is a world-leading research and innovation hub in nanoelectronics and digital technologies and is a leader in combining microchip technology, software, and ICT. Imec’s research bridges the gap between fundamental research at universities and technology development in industry.